A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization

Completed · Phase 2

Conditions studied: Pneumonia, Bacterial

In brief

The purpose of this study is to test if intravenous sulopenem and an oral drug, PF-03709270 are safe and effective in patients that are hospitalized with community acquired pneumonia.

Key facts

Study ID

NCT00797108

Run by

Pfizer

People needed

35

Starts

2009-01-01

Expected to finish

2009-06-01

Last updated by the study team

2016-03-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Hospitalized male or female patients 18 years of age or older.
• Female patients of childbearing potential must not be pregnant.
• Must exhibit at least two pre-specified clinical symptoms/signs of pneumonia.
• Must require hospitalization for the pneumonia.
• Chest Xray must be suggestive of a pneumonia.

You may not qualify if…

• Hospital or ventilator associated pneumonia.
• Patients with cystic fibrosis, pneumocystis carinii pneumonia or active tuberculosis.
• Previous treatment for the current pneumonia episode received for more than 24 hours.
• Allergies to penems or beta lactams.

Where it is running

• eStudySite, Inc. — Chula Vista, California, United States
• Sharp Chula Vista Medical Center — Chula Vista, California, United States
• eStudySite, Inc. — Oceanside, California, United States
• Tri-City Medical Center — Oceanside, California, United States
• Medical Arts Associates, Ltd — Moline, Illinois, United States
• Trinity Medical Center — Rock Island, Illinois, United States
• Infectious Disease Minneapolis Limited — Minneapolis, Minnesota, United States
• Summa Health System — Akron, Ohio, United States
• Summa Health System — Akron, Ohio, United States
• Summa Health System — Akron, Ohio, United States
• Utah Valley Pulmonary Clinic — Provo, Utah, United States
• Utah Valley Regional Medical Center — Provo, Utah, United States
• Infection Management Services, Building 17, Level 1 — Brisbane, Queensland, Australia
• Hamilton Health Sciences - General Site — Hamilton, Ontario, Canada
• Hamilton Health Sciences- McMaster Site — Hamilton, Ontario, Canada
• Hamilton Health Sciences - Henderson Site — Hamilton, Ontario, Canada
• Oddzial Chorob Wewnetrznych i Gastroenterologii — Bialystok, Poland
• Oddzial Chorob Pluc — Brzesko, Poland
• Kliniczny Oddzial Gruzlicy i Chorob Pluc — Krakow, Poland
• Oddzial Kliniczny Pulmonologii i Alergologii — Lodz, Poland
• Oddzial Pulmonologiczny III — Poznan, Poland
• Oddzial Pulmonologiczny — Proszowice, Poland
• II Oddzial Chorob Wewnetrznych — Warsaw, Poland
• Asan Medical Center, Division of Infectious Diseases — Seoul, South Korea

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.